Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study
| dc.contributor.author | Klimek, Ludger | |
| dc.contributor.author | Price, David | |
| dc.contributor.author | Galffy, G. | |
| dc.contributor.author | Emmeluth, M. | |
| dc.contributor.author | Koltun, A. | |
| dc.contributor.author | Kopietz, F. | |
| dc.contributor.author | Nguyen , D.T | |
| dc.contributor.author | Van Weissenbruch, R. | |
| dc.contributor.author | Pohl, W | |
| dc.contributor.author | Kuhl, H. C. | |
| dc.contributor.author | Scadding, G. | |
| dc.contributor.author | Mullol, J. | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2021-03-23T20:28:01Z | |
| dc.date.available | 2021-03-23T20:28:01Z | |
| dc.date.issued | 2020-10-01 | |
| dc.description | Acknowledgements: We would like to thank the subjects who participated in the trial. Funding Sources: This study was supported by MEDA Pharma GmbH & Co. KG (a Mylan Company), Bad Homburg, Germany. Technical, editorial, and medical writing assistance were provided under the direction of the authors by Strategix, an affiliate of The Lynx Group, LLC. This assistance was supported by MEDA Pharma GmbH & Co. KG (a Mylan Company). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 11 | |
| dc.format.extent | 473561 | |
| dc.identifier | 171213041 | |
| dc.identifier | 2981c2b5-1d72-4299-8934-bf866d0be5c7 | |
| dc.identifier | 32829329 | |
| dc.identifier | 85092681822 | |
| dc.identifier | 000576042300003 | |
| dc.identifier.citation | Klimek, L, Price, D, Galffy, G, Emmeluth, M, Koltun, A, Kopietz, F, Nguyen , D T, Van Weissenbruch, R, Pohl, W, Kuhl, H C, Scadding, G & Mullol, J 2020, 'Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study', International Archives of Allergy and Immunology, vol. 181, no. 10, pp. 754-764. https://doi.org/10.1159/000508749 | en |
| dc.identifier.doi | 10.1159/000508749 | |
| dc.identifier.iss | 10 | en |
| dc.identifier.issn | 1018-2438 | |
| dc.identifier.uri | https://hdl.handle.net/2164/16112 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85092681822&partnerID=8YFLogxK | en |
| dc.identifier.vol | 181 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | International Archives of Allergy and Immunology | en |
| dc.subject | Allergic rhinitis | en |
| dc.subject | Allergic rhinitis phenotype | en |
| dc.subject | Comorbidities | en |
| dc.subject | Immunoglobulin E response | en |
| dc.subject | Visual analog scale | en |
| dc.subject | R Medicine | en |
| dc.subject | Immunology and Allergy | en |
| dc.subject | Immunology | en |
| dc.subject.lcc | R | en |
| dc.title | Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Klimek_etal_Effect_of_Specific_VOR.pdf
- Size:
- 462.46 KB
- Format:
- Adobe Portable Document Format
